Phase II trial of cenderitide in hospitalised patients with acute decompensated heart failure.

Trial Profile

Phase II trial of cenderitide in hospitalised patients with acute decompensated heart failure.

Planning
Phase of Trial: Phase II

Latest Information Update: 05 Apr 2012

At a glance

  • Drugs Cenderitide (Primary)
  • Indications Decompensated heart failure
  • Focus Therapeutic Use
  • Sponsors Nile Therapeutics
  • Most Recent Events

    • 05 Apr 2012 Planned initiation date changed from 1 Jan 2012 to 1 Jun 2012.
    • 02 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top